Latest news

Filter by category:

FILTER: ALL CATEGORIESFilter by:

Latest news

05 Jun 2020

The University of Queensland, CEPI and CSL partner to advance development and manufacture of COVID-19 vaccine candidate
CEPI and CSL will fund the development and manufacture of UQ’s “molecular clamp” enabled vaccine against COVID-19. 

Read more

Read article

04 Jun 2020

CEPI partners with AstraZeneca to manufacture 300 million globally accessible doses of COVID-19 vaccine
CEPI will invest a total of up to $383m in this partnership to support the manufacture the AZD1222 vaccine candidate.

Read more

03 Jun 2020

CEPI awards up to US $14.1 million to consortium of IVI and Bharat Biotech to advance development of Chikungunya vaccine in collaboration with Ind-CEPI
CEPI to partner with Bharat Biotech and IVI to advance clinical development and manufacturing of vaccine candidate against Chikungunya.

Read more

26 May 2020

Novavax COVID-19 vaccine candidate begins clinical trials
The Novavax vaccine candidate is the fourth CEPI-funded COVID-19 vaccine to enter the clinic.

Read more

11 May 2020

CEPI extends collaboration with Novavax to advance development and manufacture of COVID-19 vaccine
CEPI to provide up to an additional US $384 million funding for phase 1 and 2 clinical trials and large-scale manufacture of Novavax’s vaccine candidate.

Read more

05 May 2020

CEPI launches new funding opportunity to accelerate COVID-19 vaccine development and production
Focus of call will be on vaccine candidates that have the potential to be developed rapidly and manufactured globally at scale.

Read more

27 Apr 2020

CEPI announces COVID-19 vaccine development partnership with Clover Biopharmaceuticals’ Australian Subsidiary
Partnership becomes ninth global COVID-19 vaccine development project that CEPI has signed since Jan 23, 2020.

Read more

27 Apr 2020

CEPI establishes Representative Office in Shanghai, China
CEPI will seek cooperation with China in the prevention and control of pandemic diseases

Read more

Read article

24 Apr 2020

Landmark global collaboration launched to defeat COVID-19 pandemic
Global leaders unite to launch Access to COVID-19 Tool (ACT) accelerator

Read more

23 Apr 2020

Oxford University vaccine against COVID-19 starts clinical tests
Oxford COVID-19 vaccine is the third CEPI-funded programme to enter phase 1 trials

Read more

21 Apr 2020

Saudi Arabia pledges US$150 million to CEPI COVID-19 response
Contribution from Saudi Arabia will help CEPI continue its rapid progress towards developing a vaccine.

Read more

©2020 CEPI. All rights reserved

This website uses cookies to improve functionality and performance. If you continue browsing the site, you consent to the use of cookies on this website. For details, see our Cookie Notice.